Created at 5:51 p.m. Oct, 28, 2024
Author: neurostormer
Related Note: 1504365993110 2
Rationale for change

I think putting that pegloticase is contraindicated in G6PD deficiency can help make the finding of bite cells with the drug more intuitive (since it happens in people with G6PD deficiency)

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#B&B::13_Immunology::05_Inflammatory_Disorders::02_Gout_Drugs::Extra #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::08_Acute_and_Chronic_Gout_Treatment #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::05_Gout_Medications #AK_Other::!AK_UpdateTags::AnKing_Image::NikolausClodi #AK_Step1_v12::#OME::PreClinical::Musculoskeletal #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::02_Gout_Drugs #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs::01_Chronic_gout_drugs_(preventive)::*Pegloticase_Rasburicase #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::01_RBC_morphology::*Degmacyte